Arsenal Capital Partners, a NY-based private equity firm, has acquired Certara, a provider of model-based drug development and data analytics software and consulting services to the biopharma R&D market.   Certara provides integrated solutions consisting of computer-based models supported by scientific consulting services that span the discovery, preclinical and clinical stages of drug development. Certara’s solutions aim to provide clients with reductions in the time and expense of bringing...